Beating the odds: Successful establishment of a Phase II/III clinical research trial in resource-poor Liberia during the largest-ever Ebola outbreak
Open Access
- 24 June 2016
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 4, 68-73
- https://doi.org/10.1016/j.conctc.2016.06.008
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Institutes of Health (HHSN261200800001E)
- National Institute of Allergy and Infectious Diseases
This publication has 8 references indexed in Scilit:
- Ebola and Its Control in Liberia, 2014–2015Emerging Infectious Diseases, 2016
- Conducting clinical trials in outbreak settings: Points to considerClinical Trials, 2016
- Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus DiseaseEmerging Infectious Diseases, 2016
- Community-Centered Responses to Ebola in Urban Liberia: The View from BelowPLoS Neglected Tropical Diseases, 2015
- The International Ebola EmergencyNew England Journal of Medicine, 2014
- “A Study in Nature”: The Tuskegee Experiments and the New South PlantationJournal of Medical Humanities, 2009
- Ring Vaccination and Smallpox ControlEmerging Infectious Diseases, 2004
- Pfizer accused of testing new drug without ethical approvalBMJ, 2001